Despite this, our labelled proline uptake experiments indicated uptake of extracellular proline in Ras/Src/Path-tumours but not in Ras/Src/CG1139-tumours (Fig. 5j), suggesting that CG1139 and Path may exhibit different activities in the context of an oncogenic background. This evidence concerns the gene SRC and neoplasm.